Cite
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
MLA
Dimitropoulos K, and Gravas S. “Solifenacin/Tamsulosin Fixed-Dose Combination Therapy to Treat Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia.” Drug Design, Development and Therapy, vol. 2015, no. default, Mar. 2015, pp. 1707–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.47f0b2492f364b5d859c17b027264958&authtype=sso&custid=ns315887.
APA
Dimitropoulos K, & Gravas S. (2015). Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Drug Design, Development and Therapy, 2015(default), 1707–1716.
Chicago
Dimitropoulos K, and Gravas S. 2015. “Solifenacin/Tamsulosin Fixed-Dose Combination Therapy to Treat Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia.” Drug Design, Development and Therapy 2015 (default): 1707–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.47f0b2492f364b5d859c17b027264958&authtype=sso&custid=ns315887.